MDLN Stock: Price, Earnings History and SEC Filings
Medline Inc. (MDLN) last traded at $32.12, up 0.37% on the latest session and down 7.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.47 against an analyst estimate of $0.30, a beat of 56.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MDLN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.47 | $0.30 | +56.67% |
| Mar 2026 | May 6, 2026 | $0.33 | $0.29 | +13.79% |
| Dec 2025 | Feb 25, 2026 | $-0.01 | $0.24 | -104.17% |
MDLN beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
How MDLN reacts to earnings
Across its last 3 earnings releases, MDLN moved 7.9% on average the next session, in either direction. It rose after 0 of 3 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-05 | Before open | -12.79% |
| 2026-05-06 | Before open | -7.30% |
| 2026-02-25 | Before open | -3.62% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
MDLN financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $28.4B | $1.2B | $1.3B | 4.1% | $-0.01 |
| 2024 | $25.5B | – | $1.4B | – | – |
| 2023 | $23.2B | – | $1.4B | – | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for MDLN
- 8-K · Oct 21, 2026Regulation FD disclosure
- 8-K · Oct 15, 2026Officer or director change
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 9, 2026Officer or director change
- 8-K · Jun 12, 2026Shareholder vote
- 8-K · Jun 2, 2026Material agreement, New financial obligation, Other events
- 424B4 · May 26, 2026
- S-1 · May 20, 2026
- 10-Q · May 6, 2026
Insider filing activity
MDLN insiders filed 8 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
MDLN news
- Medline Inc.Oct 26, 2026 · marketwatch.com
- Medline hosts fourth annual MedTrans Rodeo in Mundelein, Ill.Oct 23, 2026 · finance.yahoo.com
- What Capital Group Core Equity ETF (CGUS) Bought: Medline Leads on ThursdayOct 19, 2026 · finance.yahoo.com
About Medline Inc.
Medline Inc. (MDLN) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.